NCT05528367 2022-09-06Tirelizumab in Combination With Chemoradiation in Patients With Unresectable Gastric Cancer or Gastroesophageal Junction AdenocarcinomaZhejiang Cancer HospitalPhase 2 Unknown33 enrolled